key: cord-0314176-sntv23cv authors: Huang, X.; Yao, M.; Tian, P.; Wong, J. Y. Y.; Liu, Z.; Zhao, J. V. title: Shared genetic etiology and causality between COVID-19 and venous thromboembolism: evidence from genome-wide cross trait analysis and bi-directional Mendelian randomization study date: 2022-05-21 journal: nan DOI: 10.1101/2022.05.21.22275413 sha: 886c3a2e49ed9fa5430dcc1c40b0839c3525daf6 doc_id: 314176 cord_uid: sntv23cv Venous thromboembolism (VTE) occurs in up to one third patients with COVID-19. VTE and COVID-19 may share a common genetic architecture in etiology, which has not been comprehensively investigated. In this study, we leveraged summary-level data from the latest COVID-19 host genetics consortium and UK Biobank to study the genetic commonality between COVID-19 traits and VTE. We found a positive genetic correlation between COVID-19 hospitalization and VTE (rg = 0.2320, P-value= 0.0092). The cross-trait analysis identified shared genetic loci between VTE and COVID-19 traits, including 8 for severe COVID-19, 11 for COVID-19 hospitalization, and 7 for SARS-CoV-2 infection. We identified seven novel mapped genes (LINC00970, TSPAN15, ADAMTS13, F5, DNAJB4, SLC39A8 and OBSCN) that were enriched for expression in the lung tissue, and in coagulation and immune related pathways. Eight genetic loci were found to share causal variants between COVID-19 and VTE, which are localized in the ABO, ADAMTS13 and FUT2 gene regions. Bi-directional Mendelian randomization analysis did not suggest a causal relationship between VTE and COVID-19 traits. Our study advances the understanding of shared genetic etiology of COVID-19 and VTE at the molecular and functional levels. Coronavirus Disease (COVID-19) has led to a worldwide pandemic, with venous thromboembolism (VTE) as a serious comorbidity. Thrombotic events occur in up to one-third of patients with COVID-19, and are associated with higher risk of mortality 1 . More pronounced thrombotic symptoms seem to be associated with a severe disease course, increasing the risk of death by up to 18-fold 2 . The cytokine storm and excessive inflammation caused by SARS-CoV-2 infection is hypothesized to lead to the systemic coagulation dysfunction [3] [4] [5] [6] , therefore many institutional evidence-based guidelines supported the use of prophylactic measures such as anticoagulants for thromboprophylaxis in COVID-19 patients 7 . Although observational studies have reported a high incidence of VTE in COVID-19 patients 3, [8] [9] [10] [11] , but the underlying complex mechanisms remain unclear, and related meta-analysis comparing the overall risk of VTE occurrence in COVID-19 and non-COVID-19 cohorts gave conflicting results 12, 13 . Large-scale genome-wide association studies (GWASs) have identified multiple human genomic regions that may influence the risk of COVID-19 outcomes (severe COVID-19, COVID-19 hospitalization, and SARS-CoV-2 infection) [14] [15] [16] [17] [18] , including some genes associated with coagulation and thrombosis, such as the ABO and ACE2 genes. However, to the best of our knowledge, no large-scale genome-wide studies have systematically reported shared genetic architecture between COVID-19 and VTE. To fill this research gap, we performed a large-scale cross-trait analysis for VTE and three COVID-19 related traits to estimate their genetic correlations and shared genetic components using publicly available summary level data from GWASs of VTE and COVID-19 in the populations of multiple ancestries, and to provide novel insights into the underlying shared genetic etiology between VTE and COVID-19. We further applied two-sample bi-directional Mendelian randomization methods on VTE and three COVID-19 outcomes to investigate their causal associations. The GWAS summary statistics for COVID-19 of European ancestry were provided by the COVID-19 host genetics initiative round 7 (https://www.covid19hg.org/results/, release date: April 08, 2022). We studied three related traits of COVID-19: (1) Severe COVID-19, defined as COVID-19-confirmed individuals with very severe respiratory symptoms or those who died from the disease (up to 13,769 cases and 1,072,442 controls); (2) COVID-19 hospitalization defined as individuals who were We used summary statistics on the GWAS of VTE (3,900 cases and 369,592 controls) in the UK Biobank of European ancestry. Participating cohorts of COVID-19 and VTE were described in detail in the Supplementary Note. LDSC analysis was conducted to assess the heritability for a single trait and genetic correlations between two traits. The analysis was conducted using the LDSC software based on the GWAS summary statistics. LD scores of 1000G European ancestry was used as reference 20 . An estimate of the heritability or genetic correlation can be obtained by regressing the χ 2 statistics or the products of z-scores on LD scores, respectively. LDSC can also correct for the inflation of test statistics caused by polygeneicity 17 . We performed partitioned LDSC analysis to estimate the genetic correlation between two traits within each of the following 12 functional categories 21 : conserved region, DNaseI digital genomic footprinting region (DGF), DNase I hypersensitivity sites (DHS), fetal DHS, H3K4me1, H3K4me3, H3K9ac and H3K27ac, intron region, super enhancers, transcription factor-binding site (TFBS) and transcribed region. The recalculated LD scores of the SNPs classified in each specific annotation category allowed us to find out which functional categories accounted for the majority of the overall genetic correlation. We applied MTAG to identify novel loci with strong signals for COVID-19, and to detect shared genetic variants for VTE and three COVID-19 traits [22] [23] [24] . MTAG can improve the effect estimates for each COVID-19 trait by incorporating the weighted sum of GWAS estimates for VTE. We also used MTAG to conduct cross-trait metaanalysis, which utilizes sample size-weighted, fixed-effect model together with genetic covariance modeling from all sources to combine evidence of the association between individual variants for VTE and COVID-19. For the significant shared loci between two traits, we used the Bayesian fine-mapping algorithm to identify a 99%-credible set of causal variants for each of the shared loci within 500kb of the index SNP 25 . Then, we conducted the co-localization analysis to check whether COVID-19 and VTE association signals co-localized at shared loci, by calculating the probability that two traits shared the same causal variant (P(H 4 )) 26 . If P(H 4 ) is greater than 0.5 for any SNP, we labelled it as a co-localized genetic variant. In order to test whether the shared genes are overly expressed in a specific tissue, we performed TSEA with the HUGO Gene Nomenclature Committee (HGNC) name of genes that correspond with the shared loci in cross-trait meta-analysis. We used the R package 'deTS', which uses GTEx RNA-seq data and the ENCODE panel as a reference panel, and calculates the corresponding z-score for each tissue 27 . We also used the WEB-based GeEne SeT AnaLysis Toolkit to further assess the overrepresented enrichment of the same shared genes in Gene ontology (GO) biological process 28 . We extracted genome-wide independent significant loci for COVID-19 related tratis (severe COVID-19, COVID-19 hospitalization and SARS-CoV-2 infection) and for VTE using the genome-wide significance threshold P-value<5×10 -8 , clumped at LD threshold r 2 =0.01 and clump size 500kb. Using these SNPs as instruments, we conducted two-sample bidirectional MR analysis to assess the causal association between each COVID-19 realted trait and VTE. The effect estimate with P-value <0.05 for the main inverse variance weighted (IVW) analysis was considered to be supportive evidence 29 , and we used the weighted median 30 , MR-Egger 31 , MR-PRESSO 32 and MR-RAPS 33 methods to compare MR estimates between different MR models for sensitivity analysis. The details of methods were provided in the Supplemental Note. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Based on the HGI updated GWAS meta-analysis, there are 45 genome-wide significant (P<5×10 -8 ) and uncorrelated (r 2 <0.01) loci for severe COVID-19, 46 for Table 3 ), and 12 for VTE in the GWAS from UK Biobank (Supplementary Table 4 ). Using MTAG incorporating information from GWAS of VTE did not identify additional genome-wide significant loci for COVID-19 traits. As shown in Table 1 , we identified 8 shared novel genetic loci associated with both VTE and severe COVID-19, 11 with both VTE and COVID-19 hospitalization and 7 with both VTE and SARS-CoV-2 infection (Pmeta < 5×10 -8 ; single trait P <0.05). (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 21, 2022. ; with VTE, the strongest association signals were localized on or near the ABO gene (index SNP: rs11244061 for COVID-19 hospitalization, Pmeta=3.64×10 -28 ; rs550057 for SARS-CoV-2 infection, Pmeta=1.56×10 -51 ) at locus 9q34.2. For each of the shared loci of VTE with COVID-19, Supplementary Tables 5-7 listed all SNPs within 500 kb of these variants in the 99% credible sets. Co-localization analysis shows that those genetic loci sharing causal variants are located in ABO (index SNPs: rs11244061, rs138683771, rs8176686, rs550057, rs9411367, rs71503180), ADAMTS13 (index SNPs: rs149181677) genes on chromosome 9 and FUT2 (index SNP: rs492602) gene on chromosome 19 (Table 1) . The identified shared genes for severe COVID-19 and COVID-19 hospitalization with VTE are significantly enriched for expression in the lung tissue, no highly enriched tissues were found for SARS-CoV-2 infection and VTE (Figure 4 ). GO analysis highlighted several significant shared biological processes between three COVID-19 traits and VTE, such as "calcium-mediated signaling", "second-messenger-mediated signaling", "chemokine-mediated signaling pathway", "response to chemokine", "response to type I interferon" (Supplementary Table 8-10) . We used 45 SNPs for severe COVID-19, 46 SNPs for COVID-19 hospitalization and 26 SNPs for SARS-CoV-2 infection as instruments to the GWAS of VTE. There was null association of genetically predicted COVID-19 with VTE ( Figure 5 ). In the reverse direction, using 12 SNPs as instruments, we also found null associations of genetically predicted VTE with three COVID-19 traits ( Figure 6 ). These results are robust to different MR methods ( Supplementary Figures 1 and 2 ). All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 21, 2022. ; In this study, we investigated the shared genetic etiology and causality between three COVID-19 related traits and VTE based on the latest data from COVID-19 HGI and UK Biobank. We identified 8 genome-wide shared loci for severe COVID-19, 11 for COVID-19 hospitalization and 7 for SARS-CoV-2 infection with VTE, respectively, with mapped genes were enriched mainly in the lung tissue, and in coagulation and immune related pathways. Bi-directional MR did not provide strong evidence of their causal relationships. Our LDSC analysis showed a significant positive genetic correlation between VTE and COVID-19 hospitalization. Although LDSC analysis did not find significant overall genetic correlation between severe COVID-19 and VTE, however partitioned Interestingly, we found a strong, shared signal by severe COVID-19 and VTE located at locus 1q24.2 in LINC00970 close to NME7 gene. Locus 1q24.2 has been found to be associated with VTE previously 42 , but has not been linked to severe COVID-19. This locus (1q24.2) also includes shared genetic variant in F5 which encodes plasma All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 21, 2022. ; https://doi.org/10.1101/2022.05.21.22275413 doi: medRxiv preprint procoagulant factor (F)V involved in thrombin activation, and its impaired downregulation is key to thrombosis 43 . Similarly, ABO, FUT2, and ADAMST13 are well-established VTE related genes 42, 44 , and were found in the colocalization analysis. Growing evidence supports that thrombophilia is closely related to COVID-19 susceptibility and severity 45, 46 . Multiple studies have reported that ABO gene is associated with severe COVID-19 and SARS-CoV-2 infection [14] [15] [16] 34 , possibly by regulating thrombosis 14, 47 . This is also supported by our colocalization results. FUT2 gene, a fucosyltransferase gene involved in ABO blood group antigen synthesis, was recently found to be associated with critical COVID-19 17 . ADAMST13, which encodes protein ADAMST13, is identified to be a novel shared gene in our study. ADAMTS13 function might be affected by ABO blood group 48 , and a previous MR study showed genetically predicted ADAMST13 is associated with severe COVID-19 49 . hospitalization with VTE were also mapped to the IFNAR2 gene at 21q22.11 and NAPSA gene at 4q24. IFNAR2 gene encodes interferon receptor subunit that mediates the early host immune response to viral infection 18 . NAPSA gene is associated with damage-associated transient progenitors promoted by inflammation 39, 50 . Other shared genes have been known to be associated with innate antiviral defenses (SLC6A20) 14, 51 , immune cell signaling regulation (WNT3, TSPAN15) 52,53 , inflammatory lung injury (SLC39A8) 54 or tumor activation (TSPAN15, DNAJB4, OBSCN) [55] [56] [57] . These results imply that immune function may be related to both COVID-19 and VTE. The findings from enrichment analysis also suggest immune function might be involved in the shared etiology. In the enrichment analysis, we found several shared pathways related to immune function, such as calcium-mediated signaling and chemokine/interferon related response. The role of calcium signaling in platelets for hemostasis and thrombosis has been previously reported 58, 59 . Calcium signaling is also of paramount importance in immune cells 60, 61 , and chemokine and interferon play a major role in activating host immune and inflammatory responses [62] [63] [64] . These All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 21, 2022. ; https://doi.org/10.1101/2022.05.21.22275413 doi: medRxiv preprint evidences suggest that the common pathways between COVID-19 and VTE may relate to immunity, endothelial cell function, and coagulation. Our TSEA reported that shared genes for severe COVID-19 and COVID-19 hospitalization with VTE were mainly enriched for expression in the lung tissue. Consistently, pulmonary vascular endothelial injury and immunothrombosis (most of which occur within the lung microvessels) are key drivers of severe events after SARS-CoV-2 infection, such as acute respiratory failure and ARDS 45, 65 Our study also adds to the evidence regarding the causal relationship between VTE and COVID-19 traits. Interestingly, using bi-directional MR, we shows null associations between VTE and COVID-19 traits. Previously, a cohort study in the UK Biobank (n=312,378) showed that VTE is a risk factor for severe COVID-19 66 . However, conventional observationally studies might be subject to residual confounding bias, such as, by socioeconomic position or health status. Different from our findings, a previous MR study using COVID-19 HGI release 5 data found that genetically predicted VTE was associated with higher risk of COVID-19 hospitalization and SARS-CoV-2 infection. Although null association in MR studies might be due to a lack of power, we used data from COVID-19 HGI release 7 with doubled sample size compared to release 5, so the null association is less likely to be due to insufficient power. Meanwhile, our MR analysis did not find that genetically predicted COVID-19 was associated with an increased risk of VTE. Partly consistent with our results, a meta-analysis of cohort studies found no difference in VTE risk among people with (n= 3,060) and without COVID-19 (n=38,708) 12 . Our study is the first to use large-scale genetic data to explore the shared genetic architecture between COVID-19 related traits and VTE, providing timely evidence and novel insights about the genetic etiology between the two diseases. The GWAS summary-level data for COVID-19 was obtained from the COVID19 HGI release 7 summary statistics, the largest and latest GWAS of COVID-19 available, which doubles the sample size from previous versions and improves reliability and genetic robustness. Applying the analysis to a large publicly available COVID-19 HGI and All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 21, 2022. ; https://doi.org/10.1101/2022.05.21.22275413 doi: medRxiv preprint the UK Biobank enables us to examine the association in a well-powered study in a cost-efficient manner. We also acknowledge several limitations of our study. First, the GWAS data for COVID-19 and VTE used in this study were derived from the European population, so the associations may not be applicable to other ancestries. Second, although GWAS summary statistics conducted study-specific quality control, misclassification of COVID-19 might exist. Third, the summary statistics limit us to assess sex and age-specific genetic effects. Fourth, the GWAS of COVID-19 related traits might be All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 21, 2022. ; The x-axis represents the 12 functional categories and the y-axis represents the estimated partitioned genetic correlation. The significant functional categories (P<0.05) are starred. DGF: DNaseI digital genomic footprinting; DHS: DNase I hypersensitivity site; TFBS: transcription factor binding sites. Each point represents a SNP, and shared significant loci with meta-analysis P-value < 5×10 -8 and single-trait P-value < 0.05 are colored in red. SNPs are arranged according to the chromosome position. Causal effect estimates are presented as odds ratios (OR) with 95% confidence intervals (CI). Causal effect estimates are presented as odds ratios (OR) with 95% confidence intervals (CI). An arrow represents the estimate is out of boundary in this direction. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 21, 2022. ; https://doi.org/10.1101/2022.05.21.22275413 doi: medRxiv preprint The authors reported no funding received for this study. The authors have no competing interests. The draft was written by Xin Huang. Data analysis were performed by Minhao Yao and Peixin Tian. Xin Huang and Minhao Yao interpreted the results. Zhonghua Liu and Jie V. Zhao developed the study conception, directed the study's analytic strategy and contributed to the critical revision of the manuscript for important intellectual content. All authors read and approved the final manuscript. The study is an analysis using publicly available summary data that does not require ethical approval. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Incidence of venous thromboembolism in hospitalized patients with COVID-19 Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic COVID-19: consider cytokine storm syndromes and immunosuppression of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis. Blood advances, bloodadvances Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis Incidence of venous thromboembolism among patients with severe COVID-19 requiring mechanical ventilation compared to other causes of respiratory failure: a prospective cohort study Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis Venous Thromboembolism in COVID-19 Compared to Non Genomewide Association Study of Severe Covid-19 with Respiratory Failure Mapping the human genetic architecture of COVID-19 Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity Whole genome sequencing reveals host factors underlying critical Covid-19 Genetic mechanisms of critical illness in COVID-19 The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic LD Score regression distinguishes confounding from polygenicity in genome-wide association studies Partitioning heritability by functional annotation using genomewide association summary statistics Multi-trait analysis of genome-wide association summary statistics using MTAG Genome-wide association study of cerebral small vessel disease reveals established and novel loci A genome-wide cross-phenotype meta-analysis of the association of blood pressure with migraine Genetic and epigenetic fine mapping of causal autoimmune disease variants Bayesian test for colocalisation between pairs of genetic association studies using summary statistics deTS: tissue-specific enrichment analysis to decode tissue specificity WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 Mendelian randomization analysis with multiple genetic variants using summarized data Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases Statistical inference in twosample summary-data Mendelian randomization using robust adjusted profile score AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci. medRxiv Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors. medRxiv An integrated encyclopedia of DNA elements in the human genome Chromatin marks identify critical cell types for fine mapping complex trait variants Transcription factor binding sites and other features in human and Drosophila proximal promoters New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations. medRxiv Mapping the human genetic architecture of COVID-19: an update. medRxiv An integrative multiomics analysis identifies putative causal genes for COVID-19 severity A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation Next-generation sequencing study finds an excess of rare, coding single-nucleotide variants of ADAMTS13 in patients with deep vein thrombosis Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 COVID-19 diagnosis and management: a comprehensive review An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13 Coagulation factors and the incidence of COVID-19 severity: Mendelian randomization analyses and supporting evidence A molecular single-cell lung atlas of lethal COVID-19 Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors Signaling in the Regulation of Immune Cell and Cancer Therapeutics Editorial: Functional Relevance of Tetraspanins in the Immune System The human zinc transporter SLC39A8 (Zip8) is critical in zinc-mediated cytoprotection in lung epithelia HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer A comprehensive genomic meta-analysis identifies confirmatory role of OBSCN gene in breast tumorigenesis Tspan15 Is a New Stemness-Related Marker in Hepatocellular Carcinoma Intercellular calcium communication regulates platelet aggregation and thrombus growth Calcium signaling in platelets Calcium signaling in immune cells Calcium signalling in T cells Chemokines: role in inflammation and immune surveillance Type I interferons in infectious disease The Many Roles of Chemokines and Chemokine Receptors in Inflammation The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications Exploring causal relationships between COVID-19 and cardiometabolic disorders: A bi-directional Mendelian randomization study. medRxiv Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians Arterial and venous thromboembolism in COVID-19: a study-level metaanalysis Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and metaanalysis of randomized controlled trials Environmental and Genetic Risk Factors Associated with Venous Thromboembolism COVID-19 and Risk of VTE in Ethnically Diverse Populations No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity This research was conducted using the summary statistics from COVID-19 host genetics consortium and UK Biobank. The authors would like to thank all participants in the study and investigators for sharing the valuable data. Genetic associations with VTE were from the UK biobank GWAS results provided by Lee Lab (https://www.leelabsg.org/resources). Genetic associations with severe COVID-19, COVID-19 hospitalization and SARS-CoV-2 infection was obtained from COVID-19 host genetics consortium GWAS meta-analyses round 7, downloaded from https://www.covid19hg.org/results/r7/.